tiprankstipranks
Advertisement
Advertisement

MIRM Stock Latest News

Mirum Pharmaceuticals price target raised to $125 from $117 at TD Cowen
The FlyMirum Pharmaceuticals price target raised to $125 from $117 at TD Cowen
1h ago
MIRM
Buy Rating on Mirum Pharmaceuticals Driven by Volixibat’s Differentiated IBAT Profile, Favorable PBC Market Dynamics, and Upside from PSC Expansion
PremiumRatings
Buy Rating on Mirum Pharmaceuticals Driven by Volixibat’s Differentiated IBAT Profile, Favorable PBC Market Dynamics, and Upside from PSC Expansion
4d ago
MIRM
Mirum Pharmaceuticals completes enrollment in EXPAND study
PremiumThe Fly
Mirum Pharmaceuticals completes enrollment in EXPAND study
11d ago
MIRM
Mirum completes enrollment in AZURE-1 study, screening in AZURE-4 study
PremiumThe Fly
Mirum completes enrollment in AZURE-1 study, screening in AZURE-4 study
22d ago
MIRM
Mirum Pharmaceuticals price target raised to $126 from $101 at Evercore ISI
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $126 from $101 at Evercore ISI
23d ago
MIRM
Mirum Pharmaceuticals reports Q4 revenue $148.93M, consensus $141.81M
PremiumThe FlyMirum Pharmaceuticals reports Q4 revenue $148.93M, consensus $141.81M
29d ago
MIRM
Mirum Pharmaceuticals sees FY26 global net product sales $630M-$650M
Premium
The Fly
Mirum Pharmaceuticals sees FY26 global net product sales $630M-$650M
29d ago
MIRM
Mirum Pharmaceuticals falls -16.5%
Premium
The Fly
Mirum Pharmaceuticals falls -16.5%
29d ago
MIRM
Mirum Pharmaceuticals price target raised to $130 from $123 at Morgan Stanley
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $130 from $123 at Morgan Stanley
29d ago
MIRM
Mirum Pharmaceuticals price target raised to $117 from $115 at TD Cowen
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $117 from $115 at TD Cowen
29d ago
MIRM
Mirum Pharmaceuticals price target lowered to $128 from $130 at RBC Capital
PremiumThe Fly
Mirum Pharmaceuticals price target lowered to $128 from $130 at RBC Capital
29d ago
MIRM
Mirum Pharmaceuticals price target raised to $125 from $98 at Stifel
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $125 from $98 at Stifel
29d ago
MIRM
Mirum Pharmaceuticals: Livmarli-Driven Outperformance and Catalyst-Rich Pipeline Underpin Buy Rating
PremiumRatingsMirum Pharmaceuticals: Livmarli-Driven Outperformance and Catalyst-Rich Pipeline Underpin Buy Rating
29d ago
MIRM
Mirum Pharmaceuticals price target lowered to $132 from $140 at Citizens
Premium
The Fly
Mirum Pharmaceuticals price target lowered to $132 from $140 at Citizens
29d ago
MIRM
Mirum Pharmaceuticals files to sell 8.96M shares of common stock for holders
Premium
The Fly
Mirum Pharmaceuticals files to sell 8.96M shares of common stock for holders
30d ago
MIRM
Is MIRM a Buy, Before Earnings?
PremiumPre-Earnings
Is MIRM a Buy, Before Earnings?
1M ago
MIRM
Mirum Pharmaceuticals initiated with an Outperform at RBC Capital
PremiumThe Fly
Mirum Pharmaceuticals initiated with an Outperform at RBC Capital
1M ago
MIRM
Mirum Pharmaceuticals receives Health Canada authorization for Livmarli tablet
PremiumThe Fly
Mirum Pharmaceuticals receives Health Canada authorization for Livmarli tablet
2M ago
MIRM
Mirum Pharmaceuticals price target raised to $115 from $95 at TD Cowen
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $115 from $95 at TD Cowen
2M ago
MIRM
Mirum Pharmaceuticals director buys $9.0M in common stock
PremiumThe FlyMirum Pharmaceuticals director buys $9.0M in common stock
2M ago
MIRM
Mirum Pharmaceuticals Completes Bluejay Acquisition, Expands Liver Portfolio
Premium
Company Announcements
Mirum Pharmaceuticals Completes Bluejay Acquisition, Expands Liver Portfolio
2M ago
8K
MIRM
Mirum Pharmaceuticals price target raised to $130 from $102 at H.C. Wainwright
Premium
The Fly
Mirum Pharmaceuticals price target raised to $130 from $102 at H.C. Wainwright
2M ago
MIRM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >